Use of a five-agent GVHD prevention regimen in recipients of unrelated donor marrow.
Zander AR, Zabelina T, Kröger N, Renges H, Krüger W, Löliger C, Dürken M, Stockschläder M, de Wit M, Wacker-Backhaus G, Bielack S, Jaburg N, Rüssmann B, Erttmann R, Kabisch H.
Zander AR, et al. Among authors: kabisch h.
Bone Marrow Transplant. 1999 May;23(9):889-93. doi: 10.1038/sj.bmt.1701745.
Bone Marrow Transplant. 1999.
PMID: 10338043
Clinical Trial.